Literature DB >> 32737752

Membrane Transporters and Channels in Melanoma.

Ines Böhme1, Roland Schönherr2, Jürgen Eberle3, Anja Katrin Bosserhoff4,5.   

Abstract

Recent research has revealed that ion channels and transporters can be important players in tumor development, progression, and therapy resistance in melanoma. For example, members of the ABC family were shown to support cancer stemness-like features in melanoma cells, while several members of the TRP channel family were reported to act as tumor suppressors.Also, many transporter proteins support tumor cell viability and thus suppress apoptosis induction by anticancer therapy. Due to the high number of ion channels and transporters and the resulting high complexity of the field, progress in understanding is often focused on single molecules and is in total rather slow. In this review, we aim at giving an overview about a broad subset of ion transporters, also illustrating some aspects of the field, which have not been addressed in detail in melanoma. In context with the other chapters in this special issue on "Transportome Malfunctions in the Cancer Spectrum," a comparison between melanoma and these tumors will be possible.
© 2020. Springer Nature Switzerland AG.

Entities:  

Keywords:  Apoptosis; Cell proliferation; Channels; Melanocyte; Melanoma; Metastasis; Mutation; Nevus; Prognosis; Transporters; Tumor development; Tumor progression

Mesh:

Substances:

Year:  2021        PMID: 32737752     DOI: 10.1007/112_2020_17

Source DB:  PubMed          Journal:  Rev Physiol Biochem Pharmacol        ISSN: 0303-4240            Impact factor:   5.545


  288 in total

1.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters.

Authors:  Stephen Ph Alexander; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

2.  Expression of P2X7 receptor increases in vivo tumor growth.

Authors:  Elena Adinolfi; Lizzia Raffaghello; Anna Lisa Giuliani; Luigi Cavazzini; Marina Capece; Paola Chiozzi; Giovanna Bianchi; Guido Kroemer; Vito Pistoia; Francesco Di Virgilio
Journal:  Cancer Res       Date:  2012-04-13       Impact factor: 12.701

3.  A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.

Authors:  Soledad R Alonso; Lorraine Tracey; Pablo Ortiz; Beatriz Pérez-Gómez; José Palacios; Marina Pollán; Juan Linares; Salvio Serrano; Ana I Sáez-Castillo; Lydia Sánchez; Raquel Pajares; Abel Sánchez-Aguilera; Maria J Artiga; Miguel A Piris; José L Rodríguez-Peralto
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

4.  Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.

Authors:  Grazia Ambrosini; Christine A Pratilas; Li-Xuan Qin; Madhavi Tadi; Oliver Surriga; Richard D Carvajal; Gary K Schwartz
Journal:  Clin Cancer Res       Date:  2012-05-01       Impact factor: 12.531

5.  High hERG1 expression in advanced melanoma.

Authors:  Annarosa Arcangeli; Maria Raffaella Romoli; Luca Boni; Gianni Gerlini; Lorenzo Tofani; Carmelo Urso; Lorenzo Borgognoni
Journal:  Melanoma Res       Date:  2013-06       Impact factor: 3.599

6.  Molecular characterization of human and rat organic anion transporter OATP-D.

Authors:  Hisanobu Adachi; Takehiro Suzuki; Michiaki Abe; Naoki Asano; Hiroya Mizutamari; Masayuki Tanemoto; Toshiyuki Nishio; Tohru Onogawa; Takafumi Toyohara; Satoshi Kasai; Fumitoshi Satoh; Masanori Suzuki; Taro Tokui; Michiaki Unno; Tooru Shimosegawa; Seiki Matsuno; Sadayoshi Ito; Takaaki Abe
Journal:  Am J Physiol Renal Physiol       Date:  2003-12

7.  TPC2 controls pigmentation by regulating melanosome pH and size.

Authors:  Andrea L Ambrosio; Judith A Boyle; Al E Aradi; Keith A Christian; Santiago M Di Pietro
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-02       Impact factor: 11.205

Review 8.  Hyponatremia and MAP-kinase inhibitors in malignant melanoma: Frequency, pathophysiological aspects and clinical consequences.

Authors:  Florence Assan; Eve Vilaine; Sandra Wagner; Christine Longvert; Philippe Saiag; Alexandre Seidowsky; Isabelle Bourgault-Villada; Ziad A Massy
Journal:  Pigment Cell Melanoma Res       Date:  2018-11-22       Impact factor: 4.693

9.  Accelerated tumor progression in mice lacking the ATP receptor P2X7.

Authors:  Elena Adinolfi; Marina Capece; Alessia Franceschini; Simonetta Falzoni; Anna L Giuliani; Alessandra Rotondo; Alba C Sarti; Massimo Bonora; Susanne Syberg; Domenica Corigliano; Paolo Pinton; Niklas R Jorgensen; Luigi Abelli; Laura Emionite; Lizzia Raffaghello; Vito Pistoia; Francesco Di Virgilio
Journal:  Cancer Res       Date:  2014-12-26       Impact factor: 12.701

10.  TRPM2 ion channel promotes gastric cancer migration, invasion and tumor growth through the AKT signaling pathway.

Authors:  Shekoufeh Almasi; Andra M Sterea; Wasundara Fernando; Derek R Clements; Paola Marcato; David W Hoskin; Shashi Gujar; Yassine El Hiani
Journal:  Sci Rep       Date:  2019-03-12       Impact factor: 4.379

View more
  1 in total

1.  Activation of TRPV4 Induces Exocytosis and Ferroptosis in Human Melanoma Cells.

Authors:  Mei Li; Jiaojiao Zheng; Tian Wu; Yulin He; Jing Guo; Jiao Xu; Chuanzhou Gao; Shuxian Qu; Qianyi Zhang; Jiayu Zhao; Wei Cheng
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.